Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amarnath Challapalli

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Genitourinary Cancer|March 17, 2021
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary BladderAmarnath Challapalli, Susan Masson, Paul White, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
[<sup>18</sup>F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancerRohini Sharma, Pablo Oriol Valls, Marianna Inglese, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Bench to Bedside Development of [<sup>18</sup>F]Fluoromethyl-(1,2-<sup>2</sup>H<sub>4</sub>)choline ([<sup>18</sup>F]D4-FCH)Amarnath Challapalli, Tara D Barwick, Suraiya R Dubash, et al.
Pilot and Feasibility Studies|August 12, 2022
Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancerLucy McGeagh, Luke A Robles, Raj Persad, et al.
Future Oncology (London, England)|October 14, 2020
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinomaSam Keeping, Yingxin Xu, Chieh-I Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical CystectomyBrian C Baumann, Walter R Bosch, Amit Bahl, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2026
International multicentric validation of a novel T classification system for cancer of the nasal vestibuleLise J van de Velde, W F Julius Scheurleer, Michal D Czerwinski, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2026
Corrigendum to "International multicentric validation of a novel T classification system for cancer of the nasal vestibule"[Eur J Cancer 235 (2026), 116245]Lise J van de Velde, W F Julius Scheurleer, Michal D Czerwinski, et al.
The New England Journal of Medicine|June 2, 2025
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell CarcinomaDanny Rischin, Sandro Porceddu, Fiona Day, et al.
The Oncologist|May 20, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy CombinationsSara Elena Rebuzzi, Aruni Ghose, Sarah Rudman, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Genitourinary Cancer|March 17, 2021
A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary BladderAmarnath Challapalli, Susan Masson, Paul White, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2019
[<sup>18</sup>F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancerRohini Sharma, Pablo Oriol Valls, Marianna Inglese, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Bench to Bedside Development of [<sup>18</sup>F]Fluoromethyl-(1,2-<sup>2</sup>H<sub>4</sub>)choline ([<sup>18</sup>F]D4-FCH)Amarnath Challapalli, Tara D Barwick, Suraiya R Dubash, et al.
Pilot and Feasibility Studies|August 12, 2022
Prostate cancer-Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancerLucy McGeagh, Luke A Robles, Raj Persad, et al.
Future Oncology (London, England)|October 14, 2020
Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinomaSam Keeping, Yingxin Xu, Chieh-I Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical CystectomyBrian C Baumann, Walter R Bosch, Amit Bahl, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2026
International multicentric validation of a novel T classification system for cancer of the nasal vestibuleLise J van de Velde, W F Julius Scheurleer, Michal D Czerwinski, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2026
Corrigendum to "International multicentric validation of a novel T classification system for cancer of the nasal vestibule"[Eur J Cancer 235 (2026), 116245]Lise J van de Velde, W F Julius Scheurleer, Michal D Czerwinski, et al.
The New England Journal of Medicine|June 2, 2025
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell CarcinomaDanny Rischin, Sandro Porceddu, Fiona Day, et al.
The Oncologist|May 20, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy CombinationsSara Elena Rebuzzi, Aruni Ghose, Sarah Rudman, et al.
Pageof 4